Literature DB >> 19226285

Self-augmentation of the lengthening of repolarization is related to the shape of the cardiac action potential: implications for reverse rate dependency.

László Virág1, Károly Acsai, Ottó Hála, Antonio Zaza, Miklós Bitay, Gábor Bogáts, Julius Gy Papp, András Varró.   

Abstract

BACKGROUND AND
PURPOSE: The aims of the present work were to study the mechanism of the reverse rate dependency of different interventions prolonging cardiac action potential duration (APD). EXPERIMENTAL APPROACH: The reverse rate-dependent lengthening effect of APD-prolonging interventions and the possible involvement of I(Kr) (rapid component of the delayed rectifier potassium current) and I(K1) (inward rectifier potassium current) were studied by using the standard microelectrode and the whole-cell patch-clamp techniques in dog multicellular ventricular preparations and in myocytes isolated from undiseased human and dog hearts. KEY
RESULTS: All applied drugs--dofetilide (1 micromol.L(-1)), BaCl(2) (10 micromol.L(-1)), BAY-K-8644 (1 micromol.L(-1)), veratrine (1 microg.mL(-1))--lengthened APD in a reverse rate-dependent manner regardless of their mode of action, suggesting that reverse rate dependency may not represent a specific mechanism of APD prolongation. The E-4031-sensitive current (I(Kr)) and the Ba(2+)-sensitive current (I(K1)) were recorded during repolarizing voltage ramps having various steepness and also during action potential waveforms with progressively prolonged APD. Gradually delaying repolarization results in smaller magnitude of I(Kr) and I(K1) currents at an isochronal phase of the pulses. This represents a positive feedback mechanism, which appears to contribute to the reverse rate-dependent prolongation of action potentials. CONCLUSIONS AND IMPLICATIONS: Action potential configuration may influence the reverse rate-dependent APD prolongation due to the intrinsic properties of I(Kr) and I(K1) currents. Drugs lengthening repolarization by decreasing repolarizing outward, or increasing depolarizing inward, currents are expected to cause reverse rate-dependent APD lengthening with high probability, regardless of which current they modify.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19226285      PMCID: PMC2697697          DOI: 10.1111/j.1476-5381.2009.00116.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Rate dependency of delayed rectifier currents during the guinea-pig ventricular action potential.

Authors:  M Rocchetti; A Besana; G B Gurrola; L D Possani; A Zaza
Journal:  J Physiol       Date:  2001-08-01       Impact factor: 5.182

2.  Contribution of IKr to rate-dependent action potential dynamics in canine endocardium.

Authors:  Fei Hua; Robert F Gilmour
Journal:  Circ Res       Date:  2004-02-12       Impact factor: 17.367

3.  Ohmic conductance through the inwardly rectifying K channel and blocking by internal Mg2+.

Authors:  H Matsuda; A Saigusa; H Irisawa
Journal:  Nature       Date:  1987 Jan 8-14       Impact factor: 49.962

4.  Rapid inactivation determines the rectification and [K+]o dependence of the rapid component of the delayed rectifier K+ current in cardiac cells.

Authors:  T Yang; D J Snyders; D M Roden
Journal:  Circ Res       Date:  1997-06       Impact factor: 17.367

5.  The slow component of the delayed rectifier potassium current in undiseased human ventricular myocytes.

Authors:  L Virág; N Iost; M Opincariu; J Szolnoky; J Szécsi; G Bogáts; P Szenohradszky; A Varró; J G Papp
Journal:  Cardiovasc Res       Date:  2001-03       Impact factor: 10.787

Review 6.  Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels.

Authors:  L M Hondeghem; B G Katzung
Journal:  Biochim Biophys Acta       Date:  1977-11-14

7.  A study of the factors responsible for rate-dependent shortening of the action potential in mammalian ventricular muscle.

Authors:  M R Boyett; B R Jewell
Journal:  J Physiol       Date:  1978-12       Impact factor: 5.182

8.  The role of the delayed rectifier component IKs in dog ventricular muscle and Purkinje fibre repolarization.

Authors:  A Varro; B Baláti; N Iost; J Takács; L Virág; D A Lathrop; L Csaba; L Tálosi; J G Papp
Journal:  J Physiol       Date:  2000-02-15       Impact factor: 5.182

Review 9.  Theoretical possibilities for the development of novel antiarrhythmic drugs.

Authors:  András Varró; Péter Biliczki; Norbert Iost; László Virág; Ottó Hála; Péter Kovács; Péter Mátyus; Julius Gy Papp
Journal:  Curr Med Chem       Date:  2004-01       Impact factor: 4.530

10.  Accumulation of slowly activating delayed rectifier potassium current (IKs) in canine ventricular myocytes.

Authors:  Milan Stengl; Paul G A Volders; Morten B Thomsen; Roel L H M G Spätjens; Karin R Sipido; Marc A Vos
Journal:  J Physiol       Date:  2003-06-20       Impact factor: 5.182

View more
  10 in total

1.  Populations of in silico myocytes and tissues reveal synergy of multiatrial-predominant K+ -current block in atrial fibrillation.

Authors:  Haibo Ni; Alex Fogli Iseppe; Wayne R Giles; Sanjiv M Narayan; Henggui Zhang; Andrew G Edwards; Stefano Morotti; Eleonora Grandi
Journal:  Br J Pharmacol       Date:  2020-08-09       Impact factor: 8.739

2.  Late sodium current contributes to the reverse rate-dependent effect of IKr inhibition on ventricular repolarization.

Authors:  Lin Wu; Jihua Ma; Hong Li; Chao Wang; Eleonora Grandi; Peihua Zhang; Antao Luo; Donald M Bers; John C Shryock; Luiz Belardinelli
Journal:  Circulation       Date:  2011-04-11       Impact factor: 29.690

Review 3.  Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk.

Authors:  András Varró; István Baczkó
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

4.  A novel computational model of the human ventricular action potential and Ca transient.

Authors:  Eleonora Grandi; Francesco S Pasqualini; Donald M Bers
Journal:  J Mol Cell Cardiol       Date:  2009-10-14       Impact factor: 5.000

5.  A new hERG allosteric modulator rescues genetic and drug-induced long-QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells.

Authors:  Luca Sala; Zhiyi Yu; Dorien Ward-van Oostwaard; Jacobus Pd van Veldhoven; Alessandra Moretti; Karl-Ludwig Laugwitz; Christine L Mummery; Adriaan P IJzerman; Milena Bellin
Journal:  EMBO Mol Med       Date:  2016-09-01       Impact factor: 12.137

6.  Icariin, a Novel Blocker of Sodium and Calcium Channels, Eliminates Early and Delayed Afterdepolarizations, As Well As Triggered Activity, in Rabbit Cardiomyocytes.

Authors:  Wanzhen Jiang; Mengliu Zeng; Zhenzhen Cao; Zhipei Liu; Jie Hao; Peipei Zhang; Youjia Tian; Peihua Zhang; Jihua Ma
Journal:  Front Physiol       Date:  2017-05-29       Impact factor: 4.566

7.  Electrical Restitution and Its Modifications by Antiarrhythmic Drugs in Undiseased Human Ventricular Muscle.

Authors:  Tamás Árpádffy-Lovas; István Baczkó; Beáta Baláti; Miklós Bitay; Norbert Jost; Csaba Lengyel; Norbert Nagy; János Takács; András Varró; László Virág
Journal:  Front Pharmacol       Date:  2020-04-30       Impact factor: 5.810

8.  Positive rate-dependent action potential prolongation by modulating potassium ion channels.

Authors:  Candido Cabo
Journal:  Physiol Rep       Date:  2022-06

9.  Diclofenac prolongs repolarization in ventricular muscle with impaired repolarization reserve.

Authors:  Attila Kristóf; Zoltán Husti; István Koncz; Zsófia Kohajda; Tamás Szél; Viktor Juhász; Péter Biliczki; Norbert Jost; István Baczkó; Julius Gy Papp; András Varró; László Virág
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

10.  A systematic strategy for estimating hERG block potency and its implications in a new cardiac safety paradigm.

Authors:  Bradley J Ridder; Derek J Leishman; Matthew Bridgland-Taylor; Mohammadreza Samieegohar; Xiaomei Han; Wendy W Wu; Aaron Randolph; Phu Tran; Jiansong Sheng; Timm Danker; Anders Lindqvist; Daniel Konrad; Simon Hebeisen; Liudmila Polonchuk; Evgenia Gissinger; Muthukrishnan Renganathan; Bryan Koci; Haiyang Wei; Jingsong Fan; Paul Levesque; Jae Kwagh; John Imredy; Jin Zhai; Marc Rogers; Edward Humphries; Robert Kirby; Sonja Stoelzle-Feix; Nina Brinkwirth; Maria Giustina Rotordam; Nadine Becker; Søren Friis; Markus Rapedius; Tom A Goetze; Tim Strassmaier; George Okeyo; James Kramer; Yuri Kuryshev; Caiyun Wu; Herbert Himmel; Gary R Mirams; David G Strauss; Rémi Bardenet; Zhihua Li
Journal:  Toxicol Appl Pharmacol       Date:  2020-03-21       Impact factor: 4.219

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.